# FDA UNTITLED_LETTER - Novartis Pharmaceuticals Corporation - August 08, 2023

Source: https://www.keypedia.com/records/untitled_letter/novartis-pharmaceuticals-corporation/cd26624a-3912-48a5-979f-444b80110332

> FDA UNTITLED_LETTER for Novartis Pharmaceuticals Corporation on August 08, 2023. Product: N/A. Access full analysis and detailed observations.

---

## Details

- Record Type: UNTITLED_LETTER
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2023-08-08

## Related Documents

- [483 - Unknown Date](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/c31e1262-2601-41e1-b055-114f96464537)
- [483 - 2019-08-21](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/46e237ea-aa74-4167-91ef-3f93ae6e17f4)
- [483 - 2022-12-09](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/b1680319-d6ed-404f-97d8-29d30a5966c6)
- [483 - 2024-08-08](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/44e0cb23-0ec8-4334-bb8c-6f66a38965a7)

## Related Officers

- [Director of Compliance Branch](https://www.keypedia.com/people/alexander-lopez/0226b709-12ab-42a4-b63b-c7e8ce64ea02)

Company: https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47